2021 EAU指南:帕博利珠单抗辅助治疗肾细胞癌(更新)

2021-12-14 欧洲泌尿外科学会 Eur Urol

2021年12月,欧洲泌尿外科学会(EAU)更新发布了帕博利珠单抗辅助治疗肾细胞癌指南。

中文标题:

2021 EAU指南:帕博利珠单抗辅助治疗肾细胞癌(更新)

英文标题:

2021 Updated European Association of Urology Guidelines on the Use of Adjuvant Pembrolizumab for Renal Cell Carcinoma

发布机构:

欧洲泌尿外科学会

发布日期:

2021-12-14

简要介绍:

2021年12月,欧洲泌尿外科学会(EAU)更新发布了帕博利珠单抗辅助治疗肾细胞癌指南。肺转移性高危肾细胞癌的辅助治疗是移植肠胃满足的衣领需求,本文主要针对帕博利珠单抗在肾细胞癌患者辅助治疗中的应用提供指导建议。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 EAU指南:帕博利珠单抗辅助治疗肾细胞癌(更新).pdf)] GetToolGuiderByIdResponse(projectId=1, id=06d031c00229e17e, title=2021 EAU指南:帕博利珠单抗辅助治疗肾细胞癌(更新), enTitle=2021 Updated European Association of Urology Guidelines on the Use of Adjuvant Pembrolizumab for Renal Cell Carcinoma, guiderFrom=Eur Urol, authorId=0, author=, summary=2021年12月,欧洲泌尿外科学会(EAU)更新发布了帕博利珠单抗辅助治疗肾细胞癌指南。, cover=https://img.medsci.cn/20211221/1640094268269_1608702.jpg, journalId=0, articlesId=null, associationId=183, associationName=欧洲泌尿外科学会, associationIntro=成立于1973年,在欧洲泌尿外科的实践、研究、教育方面具有领导地位。已有超过16000名医疗人员加入其中。提供很多泌尿外科疾病的指南,更新较快。, copyright=0, guiderPublishedTime=Tue Dec 14 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年12月,欧洲泌尿外科学会(EAU)更新发布了帕博利珠单抗辅助治疗肾细胞癌指南。肺转移性高危肾细胞癌的辅助治疗是移植肠胃满足的衣领需求,本文主要针对帕博利珠单抗在肾细胞癌患者辅助治疗中的应用提供指导建议。</span></p>, tagList=[TagDto(tagId=897, tagName=肾细胞癌), TagDto(tagId=76579, tagName=帕博利珠单抗), TagDto(tagId=112858, tagName=帕博利珠单抗(pembrolizumab)), TagDto(tagId=117298, tagName=泌尿生殖系肿瘤)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=14, categoryName=肾内科, tenant=100), CategoryDto(categoryId=26, categoryName=泌尿外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=112858, guiderKeyword=帕博利珠单抗(pembrolizumab), guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2526, appHits=96, showAppHits=0, pcHits=486, showPcHits=2430, likes=0, shares=6, comments=2, approvalStatus=1, publishedTime=Tue Dec 21 21:42:15 CST 2021, publishedTimeString=2021-12-14, pcVisible=1, appVisible=1, editorId=1608702, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=dajiong, createdTime=Tue Dec 21 21:50:36 CST 2021, updatedBy=1608702, updatedName=dajiong, updatedTime=Sat Jan 06 16:48:26 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 EAU指南:帕博利珠单抗辅助治疗肾细胞癌(更新).pdf)])
2021 EAU指南:帕博利珠单抗辅助治疗肾细胞癌(更新).pdf
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1241552, encodeId=cdcc12415520c, content=<a href='/topic/show?id=34b54848271' target=_blank style='color:#2F92EE;'>#帕博利珠单抗#</a>辅助治疗<a href='/topic/show?id=7c328264677' target=_blank style='color:#2F92EE;'>#肾细胞癌#</a>(更新), beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48482, encryptionId=34b54848271, topicName=帕博利珠单抗), TopicDto(id=82646, encryptionId=7c328264677, topicName=肾细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=循证小兵, createdTime=Sun Aug 28 14:58:34 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083424, encodeId=3e79108342495, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Thu Dec 23 07:01:12 CST 2021, time=2021-12-23, status=1, ipAttribution=)]
    2022-08-28 循证小兵

    #帕博利珠单抗#辅助治疗#肾细胞癌#(更新)

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1241552, encodeId=cdcc12415520c, content=<a href='/topic/show?id=34b54848271' target=_blank style='color:#2F92EE;'>#帕博利珠单抗#</a>辅助治疗<a href='/topic/show?id=7c328264677' target=_blank style='color:#2F92EE;'>#肾细胞癌#</a>(更新), beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48482, encryptionId=34b54848271, topicName=帕博利珠单抗), TopicDto(id=82646, encryptionId=7c328264677, topicName=肾细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=循证小兵, createdTime=Sun Aug 28 14:58:34 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083424, encodeId=3e79108342495, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Thu Dec 23 07:01:12 CST 2021, time=2021-12-23, status=1, ipAttribution=)]
    2021-12-23 微探

    学习学习

    0